Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression
Zeevi, A.; Eiras, G.; Burckart, G.; Jain, A.; Kragack, A.; Venkataramanan, R.; Todo, S.; Fung, J.; Starzl, T.E.; Duquesnoy, R.J.
Transplantation Proceedings 22(1): 60-63
1990
ISSN/ISBN: 0041-1345 PMID: 1689902 Document Number: 366537
Document emailed within 1 workday
Related Documents
Vázquez Salas, L.; Arellano, J.; MacGregor Gooch, J.; Novelo, B.; Lizola Margolis, I.; Galván Plata, M.E. 1992: Immunosuppression and blood transfusions in patients with a kidney transplant Gaceta Medica de Mexico 128(3): 253-257Ratcliffe, P.J.; Firth, J.D.; Higgins, R.M.; Smith, B.; Gray, D.W.; Morris, P.J. 1993: Randomized controlled trial of complete steroid withdrawal in renal transplant patients receiving triple immunosuppression Transplantation Proceedings 25(1 Part 1): 590
Winkler, M.; Ringe, B.; Baumann, J.; Loss, M.; Wonigeit, K.; Pichlmayr, R. 1994: Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression Clinical Chemistry 40(12): 2247-2253
Grant, D.; Rochon, J.; Levy, G. 1996: Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group Transplantation Proceedings 28(4): 2232-2233
Skivolocki, W.P.; Duguay, L.R.; Orloff, M.J. 1977: Effect of pancreatic hormones on liver regeneration in a double-liver rat bioassay Surgical Forum 28: 385-387
Hart, M.E.; Foster, P.F.; Sankary, H.N.; Ashmann, M.; Williams, J.W. 1989: Low dose immunosuppression for septic liver transplantation patients Transplantation Proceedings 21(1 Part 2): 2234-2235
Flanagan, R.J.; Storey, G.C.; Holt, D.W.; Farmer, P.B. 1982: Identification and measurement of desethylamiodarone in blood plasma specimens from amiodarone-treated patients Journal of Pharmacy and Pharmacology 34(10): 638-643
Wu, D.-B.; Liu, F.-W.; Li, J.; Liu, C.; Liu, L.; Chen, E.-Q.; Zhao, L.-S.; Tang, H.; Zhou, T.-Y. 2013: Intrahepatic IFN-alpha expression in liver specimens from HBV-infected patients with different outcomes European Review for Medical and Pharmacological Sciences 17(18): 2474-2480
Snydman, D.R.; Werner, B.G.; Dougherty, N.N.; Griffith, J.; Rohrer, R.H.; Freeman, R.; Jenkins, R.; Lewis, W.D.; O'Rourke, E. 1994: A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group Transplantation Proceedings 26(5 Suppl 1: 23-27
Scharp, D.W.; Alderson, D.; Kneteman, N.M. 1987: The effects of immunosuppression on islet transplant function in the dog Transplantation Proceedings 19(1 Part 2): 952-953
Da Fonseca-Wollheim, F. 1990: Deamidation of glutamine by increased plasma gamma-glutamyltransferase is a source of rapid ammonia formation in blood and plasma specimens Clinical Chemistry 36(8 Part 1): 1479-1482
Hasselder, A. 1999: Renal transplant: long-term effects of immunosuppression Professional Nurse 14(11): 771-776
Enderlin, F.; Guisan, Y. 1973: Malignant tumors under immunosuppression, new problem in transplant recipients Schweizerische Rundschau für Medizin Praxis 62(34): 1031-1035
Michler, R.E.; Smith, C.R.; Drusin, R.E.; Reison, D.S.; Hickey, T.J.; Lamb, J.; Reemtsma, K.; Rose, E.A. 1986: Reversal of cardiac transplant rejection without massive immunosuppression Circulation 74(5 Part 2): Iii68-Iii71
Blake, B.P.; Marathe, K.S.; Mohr, M.R.; Jones, N.; Novosel, T. 2011: Viral-associated trichodysplasia of immunosuppression in a renal transplant patient Journal of Drugs in Dermatology: Jdd 10(4): 422-424
Stephens, J.; Goldstein, R.; Crippin, J.; Husberg, B.; Holman, M.; Gonwa, T.A.; Klintmalm, G. 1993: Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients Transplantation Proceedings 25(1 Part 2): 1122-1123
Toda, G.; Ikeda, Y.; Hashimoto, N.; Yamazaki, M.; Torii, M.; Oka, H. 1983: Liver cell membrane antibody detected by protein A and isolated rabbit liver plasma membrane in sera of patients with chronic liver diseases Clinical and Experimental Immunology 54(3): 661-670
Agha, I.A.; Rueda, J.; Alvarez, A.; Singer, G.G.; Miller, B.W.; Flavin, K.; Lowell, J.A.; Shenoy, S.; Howard, T.K.; Ramachandran, V.; Irish, W.; Schnitzle, M.A.; Brennan, D.C. 2002: Short course induction immunosuppression with thymoglobulin for renal transplant recipients Transplantation 73(3): 473-475
Burrows, D.A.; O'Neil, T.J.; Sorrells, T.L. 1988: Successful twin pregnancy after renal transplant maintained on cyclosporine a immunosuppression Obstetrics and Gynecology 72(3 Part 2): 459-461
Winkler, M.; Ringe, B.; Jost, U.; Gubernatis, G.; Pichlmayr, R. 1993: Plasma level-guided low-dose FK 506 therapy in patients with early liver dysfunction after liver transplantation Transplantation Proceedings 25(4): 2688-2690